Statistics

Highlights from the 2026 UNODC World Drug Report

ISSUP Webinar
 - 
This webinar highlighted key findings from the 2026 edition of the UNODC World Drug Report. The session was presented by Giovanna Campello, Chief of the Prevention, Treatment and Rehabilitation Section at the United Nations Office on Drugs and Crime (UNODC).

Highlights from the 2026 UNODC World Drug Report

Event Date
 - Online
Join our upcoming webinar highlighting key findings from the 2026 edition of the UNODC World Drug Report. The session will be presented by Giovanna Campello, Chief of the Prevention, Treatment and Rehabilitation Section at the United Nations Office on Drugs and Crime (UNODC).
2026 UNODC Drug Report Webinar flyer

European Drug Report 2026: Trends and Developments

Report
 - 
The European Drug Report 2026: Trends and Developments provides the latest overview of the drug situation across Europe, drawing on data from EU Member States, Türkiye, and Norway. The report examines patterns of drug use, drug-related...

2025 National Drug Threat Assessment (NDTA) - Drug Enforcement Administration (DEA)

Report
The U.S. Drug Enforcement Administration (DEA) has released its 2025 National Drug Threat Assessment (NDTA), providing an overview of the threats posed by illicit drugs and the transnational criminal organizations involved in their production and trafficking. The report highlights the continuing impact of synthetic drugs, particularly fentanyl and methamphetamine, on public health, public safety, and national security.
The Drug Enforcement Administration (DEA)

The Tobacco Control Scale 2025 in Europe

Report
 - 
The Tobacco Control Scale 2025 shows that progress in tobacco control across Europe has slowed, with more countries recording lower scores than in previous years. Key reasons include the failure to regulate heated tobacco products in the same way as cigarettes and the lack of adjustments to tobacco taxes and prices to keep pace with inflation.

UNODC Current NPS Threats

Report
 - 
The UNODC Early Warning Advisory highlights a continued global expansion of new psychoactive substances (NPS), with nearly 1,400 substances reported worldwide. In 2024 alone, a record number of substances were identified, including over 100...
UNOPS